"10.1371_journal.pone.0068520","plos one","2013-07-16T00:00:00Z","Sha Guo; Ying Liu; Younan Ma; Qing Zhao; Liping Zhu; Yuehu Shao; Fengying Gao; Fengqi Wu; Ruitong Gao; Wei Zhang","Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, People’s Republic of China; Department of Research and Development, Absea Biotechnology Ltd, Beijing, People’s Republic of China; Department of Internal Medicine, Pediatric Hospital of Sanhe, Langfang City, Hebei Province, People’s Republic of China; Department of Pediatric Rheumatology, Capital Institute of Pediatrics, Beijing, People’s Republic of China; Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People’s Republic of China","Conceived and designed the experiments: WZ SG YL FW. Performed the experiments: SG YL YM WZ. Analyzed the data: SG YL QZ LZ WZ. Contributed reagents/materials/analysis tools: YS FG RG FW. Wrote the paper: WZ SG YL FW RG.","Institute of Basic Medical Sciences, Capital Institute of Pediatrics and Absea Biotechnology Ltd has filed a patent application (pending). Dr. Wei Zhang is a co-founder and a shareholder of Absea. The above mentioned patent is ‘Application of antigens containing 6-N-monomethylated lysine residue in assisting diagnosis of systemic lupus erythematosus’ (No. 201310061233.8). No other competing interests exist. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Sha Guo","SG",10,TRUE,4,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
